Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruno Barsic

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Journal of Neurovirology|September 13, 2007
Virological and immunological characteristics of fatal Epstein-Barr virus mononucleosis in a 17-year-old Caucasian male presenting with meningoencephalitis and hemophagocytic syndromeAdriana Vince, Snjezana Zidovec Lepej, Ivan Kurelac, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|July 18, 2012
Chemokine CXCL10 at week 4 of treatment predicts sustained virological response in patients with chronic hepatitis CIvan Kurelac, Snjezana Zidovec Lepej, Ivana Grlgic, et al.
The Cochrane Database of Systematic Reviews|May 2, 2013
Monoclonal antibody for reducing the risk of respiratory syncytial virus infection in childrenTea Andabaka, Jason W Nickerson, Maria Ximena Rojas-Reyes, et al.
Journal of Neurovirology|November 2, 2014
First cases of human Usutu virus neuroinvasive infection in Croatia, August-September 2013: clinical and laboratory featuresMarija Santini, Tatjana Vilibic-Cavlek, Bruno Barsic, et al.
Viruses|May 28, 2025
Development and Validation of the CARRA-VID Prognostic Score: C Reactive Protein to Albumin Ratio, Red Blood Cell Distribution Width and Age-Based Score for Prognostication of Hospitalized COVID-19 PatientsMarko Lucijanic, Nevenka Piskac Zivkovic, Nikolina Busic, et al.
Journal of Medical Virology|February 21, 2022
Vaccination provides protection from respiratory deterioration and death among hospitalized COVID-19 patients: Differences between vector and mRNA vaccinesNikolina Busic, Tomo Lucijanic, Bruno Barsic, et al.
Antimicrobial Agents and Chemotherapy|November 27, 2013
Clinical experience of colistin-glycopeptide combination in critically ill patients infected with Gram-negative bacteriaNicola Petrosillo, Maddalena Giannella, Massimo Antonelli, et al.
The Journal of Infection|May 5, 2022
Remdesivir use in COVID-19 patients might predispose bacteremia, matched case-control analysisMarko Lucijanic, Tomislav Cikara, Petra Bistrovic, et al.
Expert Opinion on Drug Safety|July 7, 2023
Proton pump inhibitors use prior to COVID-19 hospitalization is associated with higher C<i>lostridioides difficile</i> infection rateMarko Lucijanic, Nikolina Busic, Josip Stojic, et al.
Wiener Klinische Wochenschrift|November 25, 2021
Asymptomatic deep vein thromboses in prolonged hospitalized COVID-19 patientsMarko Lucijanic, Nevenka Piskac Zivkovic, Marija Ivic, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Journal of Neurovirology|September 13, 2007
Virological and immunological characteristics of fatal Epstein-Barr virus mononucleosis in a 17-year-old Caucasian male presenting with meningoencephalitis and hemophagocytic syndromeAdriana Vince, Snjezana Zidovec Lepej, Ivan Kurelac, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|July 18, 2012
Chemokine CXCL10 at week 4 of treatment predicts sustained virological response in patients with chronic hepatitis CIvan Kurelac, Snjezana Zidovec Lepej, Ivana Grlgic, et al.
The Cochrane Database of Systematic Reviews|May 2, 2013
Monoclonal antibody for reducing the risk of respiratory syncytial virus infection in childrenTea Andabaka, Jason W Nickerson, Maria Ximena Rojas-Reyes, et al.
Journal of Neurovirology|November 2, 2014
First cases of human Usutu virus neuroinvasive infection in Croatia, August-September 2013: clinical and laboratory featuresMarija Santini, Tatjana Vilibic-Cavlek, Bruno Barsic, et al.
Viruses|May 28, 2025
Development and Validation of the CARRA-VID Prognostic Score: C Reactive Protein to Albumin Ratio, Red Blood Cell Distribution Width and Age-Based Score for Prognostication of Hospitalized COVID-19 PatientsMarko Lucijanic, Nevenka Piskac Zivkovic, Nikolina Busic, et al.
Journal of Medical Virology|February 21, 2022
Vaccination provides protection from respiratory deterioration and death among hospitalized COVID-19 patients: Differences between vector and mRNA vaccinesNikolina Busic, Tomo Lucijanic, Bruno Barsic, et al.
Antimicrobial Agents and Chemotherapy|November 27, 2013
Clinical experience of colistin-glycopeptide combination in critically ill patients infected with Gram-negative bacteriaNicola Petrosillo, Maddalena Giannella, Massimo Antonelli, et al.
The Journal of Infection|May 5, 2022
Remdesivir use in COVID-19 patients might predispose bacteremia, matched case-control analysisMarko Lucijanic, Tomislav Cikara, Petra Bistrovic, et al.
Expert Opinion on Drug Safety|July 7, 2023
Proton pump inhibitors use prior to COVID-19 hospitalization is associated with higher C<i>lostridioides difficile</i> infection rateMarko Lucijanic, Nikolina Busic, Josip Stojic, et al.
Wiener Klinische Wochenschrift|November 25, 2021
Asymptomatic deep vein thromboses in prolonged hospitalized COVID-19 patientsMarko Lucijanic, Nevenka Piskac Zivkovic, Marija Ivic, et al.
Pageof 4